Suppr超能文献

中国视神经脊髓炎谱系障碍患者中TPMT*3C与硫嘌呤S-甲基转移酶活性降低之间的关联。

Association between TPMT*3C and decreased thiopurine S-methyltransferase activity in patients with neuromyelitis optica spectrum disorders in China.

作者信息

Gong Xiaoqing, Mei Shenghui, Li Xindi, Li Xingang, Zhou Heng, Liu Yonghong, Zhou Anna, Yang Li, Zhao Zhigang, Zhang Xinghu

机构信息

a Neuroinfection and Neuroimmunology Center , Department of Neurology, Beijing Tiantan Hospital , Capital Medical University , Beijing , P. R. China.

b Department of Neurology, Beijing Shunyi District Hospital , Beijing , P. R. China.

出版信息

Int J Neurosci. 2018 Jun;128(6):549-553. doi: 10.1080/00207454.2017.1401621. Epub 2017 Dec 1.

Abstract

AIM OF THE STUDY

Thiopurines are effective drugs in treating neuromyelitis optica spectrum disorders and other diseases. Thiopurines' toxicity is mainly imputed to thiopurine S-methyltransferase activity. In Chinese population, the most common and important variation of thiopurine S-methyltransferase is TPMT*3C (rs1142345). This study aims to reveal the association between thiopurine S-methyltransferase activity and genetic polymorphisms of thiopurine S-methyltransferase in patients with neuromyelitis optica spectrum disorders in China.

MATERIAL AND METHODS

A liquid chromatography tandem mass/mass method was used to evaluate the thiopurine S-methyltransferase activity by using 6-mercapthioprine as the substrate in human erythrocyte haemolysate via 1 h incubation at 37 °C to form its methylated product 6-methylmercaptopurine. The amount of 6-methylmercaptopurine was adjusted by haematocrit and normalized to 8 × 10 erythrocytes. The selected polymorphisms of thiopurine S-methyltransferase were identified using MassARRAY system (Sequenom) and multiple SNaPshot technique.

RESULTS

In 69 patients with neuromyelitis optica spectrum disorders, thiopurine S-methyltransferase activity was 80.29-154.53 (127.51 ± 16.83) pmol/h/8 × 10 erythrocytes. TPMT*3C (rs1142345) was associated with lower thiopurine S-methyltransferase activity (BETA = -25.37, P = 0.011). Other selected variants were not associated with thiopurine S-methyltransferase activity.

CONCLUSIONS

TPMT*3C affects TPMT activity in Chinese patients with neuromyelitis optica spectrum disorders. Further studies are warranted to confirm the results.

ABBREVIATIONS

TPRs = thiopurines; NMOSD = neuromyelitis optica spectrum disorders; TPMT = thiopurine S-methyltransferase; LC-MS/MS = liquid chromatography tandem mass/mass; 6-MMP = 6-methylmercaptopurine; IS = internal standard; SNP = single nucleotide polymorphism; MAF = minor allele frequency; HWE = Hardy-Weinberg equilibrium; BETA = regression coefficients; UTR-3 = untranslated region 3.

摘要

研究目的

硫唑嘌呤是治疗视神经脊髓炎谱系障碍及其他疾病的有效药物。硫唑嘌呤的毒性主要归因于硫嘌呤S-甲基转移酶活性。在中国人群中,硫嘌呤S-甲基转移酶最常见且重要的变异是TPMT*3C(rs1142345)。本研究旨在揭示中国视神经脊髓炎谱系障碍患者硫嘌呤S-甲基转移酶活性与硫嘌呤S-甲基转移酶基因多态性之间的关联。

材料与方法

采用液相色谱串联质谱法,以6-巯基嘌呤为底物,在人红细胞溶血产物中于37℃孵育1小时,使其形成甲基化产物6-甲基巯基嘌呤,以此评估硫嘌呤S-甲基转移酶活性。6-甲基巯基嘌呤的量通过血细胞比容进行校正,并标准化为8×10个红细胞。使用MassARRAY系统(Sequenom)和多重SNaPshot技术鉴定硫嘌呤S-甲基转移酶的选定多态性。

结果

69例视神经脊髓炎谱系障碍患者中,硫嘌呤S-甲基转移酶活性为80.29 - 154.53(127.51±16.83)pmol/h/8×10个红细胞。TPMT*3C(rs1142345)与较低的硫嘌呤S-甲基转移酶活性相关(BETA = -25.37,P = 0.011)。其他选定变异与硫嘌呤S-甲基转移酶活性无关。

结论

TPMT*3C影响中国视神经脊髓炎谱系障碍患者的TPMT活性。有必要进行进一步研究以证实该结果。

缩写

TPRs = 硫唑嘌呤;NMOSD = 视神经脊髓炎谱系障碍;TPMT = 硫嘌呤S-甲基转移酶;LC-MS/MS = 液相色谱串联质谱;6-MMP = 6-甲基巯基嘌呤;IS = 内标;SNP = 单核苷酸多态性;MAF = 次要等位基因频率;HWE = 哈迪-温伯格平衡;BETA = 回归系数;UTR-3 = 3'非翻译区

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验